Marcus Boehm - 06 Dec 2021 Form 4 Insider Report for Vyant Bio, Inc.

Role
Director
Signature
/s/ Andrew LaFrence, attorney-in-fact
Issuer symbol
N/A
Transactions as of
06 Dec 2021
Net transactions value
+$8,450
Form type
4
Filing time
07 Dec 2021, 08:00:35 UTC
Previous filing
28 Oct 2021
Next filing
20 Jan 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VYNT Common Stock, $0.0001 par value Purchase $8,450 +5,000 +4% $1.69 128,786 06 Dec 2021 By Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.